Arlo N. MCGINN,Bumjin KIM,Sung Chul KIM,Cheol Hee PARK
申请号：
US16762881
公开号：
US20200282052A1
申请日:
2018.11.09
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are methods for the treatment of diseases, comprising administering a combination of a tyrosine kinase inhibitors and an immunotherapeutic agent. A method of treating cancer comprising administering to a patient in need thereof a therapeutically effective amount of apatinib in combination with a therapeutically effective amount of an immunotherapeutic agent.
